Artificial beta-cell application in two cases of insulinoma: a different pattern in beta-cell adenoma and carcinoma.
With the aid of an artificial beta-cell (Biostator, Miles Laboratories Inc.), a different metabolic and biological pattern of behaviour was observed in benign versus malignant insulinoma. In the patient with beta-cell adenoma but not in the one with carcinoma, plasma insulin concentrations decreased promptly and markedly, and blood glucose increased during diazoxide and somatostatin infusion. Moreover, only in the adenoma patient was glucose need characterized by a circadian rhythm with the maximum values during daytime. This behavior could reflect the degree of tumor beta-cell differentiation. The controlled glucose and insulin infusion was of great help during and after surgical treatment.
D000236:Adenoma / Q000175:diagnosis*; D007516:Adenoma, Islet Cell / Q000175:diagnosis*; D001187:Artificial Organs; D001786:Blood Glucose / Q000032:analysis; D002277:Carcinoma / Q000175:diagnosis*; D003937:Diagnosis, Differential; D003981:Diazoxide; D006801:Humans; D007328:Insulin / Q000008:administration & dosage / Q000097:blood; D007515:Islets of Langerhans / Q000378:metabolism*; D008991:Monitoring, Physiologic; D010190:Pancreatic Neoplasms / Q000175:diagnosis*; D013004:Somatostatin
D001786:Blood Glucose; D007328:Insulin; D013004:Somatostatin; D003981:Diazoxide